Coherus BioSciences Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. My name is Balaji Prasad. I lead the specialty pharma coverage from Barclays, and thank you for dialing in to Barclays Global Health Care Conference. Continuing the specialty pharma track for the conference, I'm pleased to introduce the management of Coherus. So we have with us today both Dennis Lanfear, President of Coherus and CEO; and McDavid Stilwell, CFO.
So we may have just take a technical glitch while we get Denny to join us. There we are.
Thank you, Denny. So Denny, thanks for joining us and McDavid. I probably (inaudible) after the significant strategic shift that you initiated earlier this year, moving in away from biosimilars (inaudible) to biologics (inaudible). So also congratulations on -- in sharing the rolling submission for toripalimab.
Questions & Answers
So I think, obviously, that's a part where -- firstly, can you take us through the native as to why you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |